bm-navigation: bm-t1-home-navigation-1

IMAGINE A WORLD IN WHICH CANCER DOESN’T WIN

bm-basic: home-our-science

OUR
MISSION

We are dedicated to developing therapeutic molecules that overcome foundational barriers that prevent patients from living longer, cancer-free lives.

About
bm-basic: home-our-programs

OUR
PROGRAMS

We recognize cancer as a chronic disease and are focused on developing therapies that address the most common cause of cancer mortality: relapse and metastasis. We believe treatments focused on modulating the foundational barriers that allow treatment-resistant cancer cells to reawaken as relapse and metastasis will meaningfully impact patient outcomes.

Programs
bm-basic: home-our-team

OUR
TEAM

We believe that overcoming foundational barriers requires collaboration of vision, scientific rigor, novel approaches and bold thought-leaders who are devoted to a shared mission.

TEAM
bm-basic: home-publications-news

HIBERCELL
NEWS

Explore our company updates and news to learn more about how we are overcoming barriers in cancer.

- Press Release

HiberCell Expands Scientific Advisory Board with Appointment of Lisa M. Coussens, Ph.D., and Ronald Wek, Ph.D.

Read More
- Press Release

HiberCell and Biodesix Initiate Broad Collaboration forCompanion Diagnostic Discovery, Development and Commercialization

Read More
- Press Release

HiberCell Bolsters Leadership Team with Appointment of Joseph Talamo as Chief Financial Officer and Promotion of Ari Nowacek, M.D., Ph.D., to Chief Business Officer

Read More
VIEW ALL
bm-basic: home-work-with-us

CAREERS

Every day at HiberCell moves us closer to a world in which cancer doesn’t win.  If you share this passion, there may be a role for you on our team.

READ MORE
READ MORE
READ MORE
LEARN MORE

OUR
INVESTORS

We are proud to be supported by some of the world’s most visionary investors in biotechnology.